Abstract

Background: Baicalein (Bai) is the principal ingredient of Scutellaria baicalensis Georgi. Reports concerning the therapeutic advantages in treating cardiovascular diseases have been published. However, its protective mechanism towards myocardial ischemia (MI) is undefined. Objective: The aim of this study was to investigate the protective mechanisms of Bai on mouse and rat models of MI. Methods: Mice were pre-treated with Bai (30 and 60 mg/kg/day) for 7 days followed by subcutaneous injections of isoproterenol (ISO, 85 mg/kg/day) for 2 days to establish the MI model. Electrocardiograms were recorded and serum was used to detect creatine kinase (CK), lactate dehydrogenase (LDH), superoxide dismutase (SOD), catalase (CAT), glutathione (GSH) and malondialdehyde (MDA). Cardiac tissues were used to detect Ca2+ concentration, morphological pathologies, reactive oxygen species (ROS), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). In addition, the expression levels of Bcl-2-associated X (Bax), B cell lymphoma-2 (Bcl-2), Caspase-3, Toll-like receptor-4 (TLR4), myeloid differentiation protein 88 (MyD88), nuclear factor-kappa B (NF-κB), p-p38, p-extracellular signal-regulated kinase1/2 (p-ERK1/2) and c-Jun N-terminal kinase (p-JNK) were assessed by western blots in myocardial tissues. The effects of Bai on L-type Ca2+ currents (ICa-L), contractility and Ca2+ transients in rat isolated cardiomyocytes were monitored by using patch clamp technique and IonOptix system. Moreover, ISO-induced H9c2 myocardial injury was used to detect levels of inflammation and apoptosis. Results: Bai caused an improvement in heart rate, ST-segment and heart coefficients. Moreover, Bai led to a reduction in CK, LDH and Ca2+ concentrations and improved morphological pathologies. Bai inhibited ROS generation and reinstated SOD, CAT and GSH activities in addition to inhibition of replenishing MDA content. Also, expressions of IL-6 and TNF-α in addition to Bax and Caspase-3 were suppressed, while Bcl-2 expression was upregulated. Bai inhibited protein expressions of TLR4/MyD88/MAPKS/NF-κB and significantly inhibited ICa-L, myocyte contraction and Ca2+ transients. Furthermore, Bai caused a reduction in inflammation and apoptosis in H9c2 cells. Conclusions: Bai demonstrated ameliorative actions towards MI, which might have been related to attenuation of oxidative stress, inflammation and apoptosis via suppression of TLR4/MyD88/MAPKS/NF-κB pathway and adjustment of Ca2+ homeostasis via L-type Ca2+ channels.

Highlights

  • Ischemic heart disease is the leading cause of disease burden worldwide (Lopez and Murray, 1998)

  • Heart rate and ST-segment in Low-dose Bai (L-Bai), High-dose Bai (H-Bai), and Ver groups had decreased when compared with ISO group (p < 0.01 or p < 0.05)

  • ISO treatment caused an enlargement of the heart and a significant decrease in body weight in mice, while heart weights from mice with cardiac hypertrophy increased

Read more

Summary

Introduction

Ischemic heart disease is the leading cause of disease burden worldwide (Lopez and Murray, 1998). Cardiomyocyte death resulting from myocardial ischemia (MI) underlies the most significant cardiovascular-related deaths (Cannon, 2005). The prevention and treatment of myocardial ischemia have significant implications in the future. Long-lasting ischemia causes irreversible cellular damage and eventually apoptosis. Pro-inflammatory cytokines exert a crucial role in heart injury (Lauer et al, 2014), and the Toll-like receptor-4/nuclear factor-kappa B (TLR4/NF-κB) pathway regulates the secretion of these cytokines. Myeloid differentiation protein 88 (MyD88) is an adapter protein that is critical for TLR4 (Singh et al, 2012) and causes enhancement of inflammation and an increase in reactive oxygen species (ROS) production Inhibition of the TLR4/NF-κB pathway averts inflammation (Hirotani et al, 2002; Lawrence, 2009; X.; Wang, 2001). Its protective mechanism towards myocardial ischemia (MI) is undefined

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call